| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
22.790 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
22.790 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
22.790 |
Evidence |
|
| DUSP14 |
DUSP14, MKP6: Dual specificity protein phosphatase 14 |
DSTN |
DSTN, ACTDP, DSN: Destrin |
22.740 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
SUMO1 |
SUMO1, SMT3C, OK/SW-cl.43, SMT3H3, UBL1: Small ubiquitin-related modifier 1 prec |
22.690 |
Evidence |
|
| CHMP6 |
CHMP6, VPS20: Charged multivesicular body protein 6 |
SNF8 |
SNF8, EAP30: Vacuolar-sorting protein SNF8 |
22.690 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
PLCB1 |
PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- |
22.620 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
22.620 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
22.620 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MOS |
MOS: Proto-oncogene serine/threonine-protein kinase mos |
22.620 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
22.620 |
Evidence |
|
| MOS |
MOS: Proto-oncogene serine/threonine-protein kinase mos |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
22.620 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
22.620 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
BIRC5 |
BIRC5, API4, IAP4: Baculoviral IAP repeat-containing protein 5 |
22.610 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
22.500 |
Evidence |
|
| CREBBP |
CREBBP, CBP: CREB-binding protein |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
22.500 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
22.500 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
22.450 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
22.450 |
Evidence |
|
| H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
22.450 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
22.450 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
22.450 |
Evidence |
O
|
| RELA |
RELA, NFKB3: Transcription factor p65 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
22.450 |
Evidence |
|
| UTX |
UTX: Ubiquitously transcribed X chromosome tetratricopeptide repeat protein |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
22.450 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
22.450 |
Evidence |
|
-